Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival.

Adams S, Chakravarthy AB, Donach M, Spicer D, Lymberis S, Singh B, Bauer JA, Hochman T, Goldberg JD, Muggia F, Schneider RJ, Pietenpol JA, Formenti SC
Breast Cancer Res Treat. 2010 124 (3): 723-32

PMID: 20878462 · PMCID: PMC3655407 · DOI:10.1007/s10549-010-1181-8

MeSH Terms (27)

Adult Antineoplastic Agents, Phytogenic Breast Neoplasms Chemotherapy, Adjuvant Chi-Square Distribution Disease-Free Survival Drug Administration Schedule Female Humans Kaplan-Meier Estimate Lymphatic Metastasis Mastectomy Middle Aged Neoadjuvant Therapy Neoplasm Invasiveness Neoplasm Recurrence, Local Neoplasm Staging Paclitaxel Proportional Hazards Models Prospective Studies Radiotherapy, Adjuvant Radiotherapy Dosage Risk Assessment Risk Factors Time Factors Treatment Outcome United States

Connections (1)

This publication is referenced by other Labnodes entities:

Links